학술논문

The Delicate Balancing Act of Childhood Cancer Treatment-Not Too Much but Not Too Little.
Document Type
Journal Article
Source
JNCI: Journal of the National Cancer Institute. May2021, Vol. 113 Issue 5, p509-510. 2p.
Subject
*CHILDHOOD cancer
*CANCER treatment
Language
ISSN
0027-8874
Abstract
As a result of marked advances in treatments, death rates from the major types of childhood cancer in the United States have decreased by more than 60% over the past several decades, from 6.3 per 100 000 population in 1970 to 2.0 per 100 000 population in 2017 (1). The authors compared all-cause and cause-specific late mortality among childhood cancer survivors in the United States with those in the United Kingdom using data from the CCSS and the population-based British Childhood Cancer Survivor Study (BCCSS). The Childhood Cancer Survivor Study (CCSS), established in 1994 across selected centers in the United States and Canada, recruited childhood cancer survivors retrospectively in 2 waves covering survivors treated in 1970 through 1999 (4). [Extracted from the article]